Weighing Drug Costs and Patient Values in Cancer Care
Cancer Care Innovations Abound, but Access and Equity Are Ongoing Challenges
Translating Best Practices and Ensuring Equitable Care as the Treatment Landscape Evolves
Understanding What Recent Court Action Means to 340B Reform
Ajai Chari, MD, on the Challenges of Bringing CAR T, Bispecifics to Patients With Multiple Myeloma
Advances in Ovarian Cancer: Using Genomics and Optimizing Maintenance Therapy
Reinventing Oncology: The Urgent Need to Address Access, Burnout, and Adherence in a Shifting Landscape
Orca-T Shows Efficacy, Reduced GVHD Risk in Acute Leukemia, MDS
While Claiming Transparency, CMS Quietly Drops Health Equity Elements of EOM
With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period
North Idaho Clinics Become Part of OneOncology
The Nashville-based managed services organization now serves 1300 providers and 747,000 patients across 420 sites of care.
As Court Action Heats Up, Study Shows More Money Made on 340B in Wealthy Areas
The findings appear as multiple lawsuits pit pharmaceutical companies against hospitals as well as HHS.
